Targeting the Gut for Early Diagnosis, Prevention, and Cure of Diabetic Kidney Disease: Is the Phenyl Sulfate Story Another Step Forward?

No abstract is available for this paper.

• Publication year

  2019

• Venue

  American Journal of Kidney Diseases

• Publication date

  Unknown publication date

• Fields of study

  Biology, Medicine

• Identifiers
  DOI 10.1053/j.ajkd.2019.07.001PMID 31451331
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Metabolomics Approaches for the Diagnosis and Understanding of Kidney Diseases

  2019cited by this paper
• Canagliflozin and Renal Outcomes in Type 2 Diabetes and Nephropathy.

  2019cited by this paper
• Gut microbiome-derived phenyl sulfate contributes to albuminuria in diabetic kidney disease

  2019cited by this paper
• Microvascular Complications and Foot Care : Standards of Medical Care in Diabetes d 2019

  2018cited by this paper
• Update on Diabetic Nephropathy: Core Curriculum 2018.

  2018cited by this paper
• SGLT2 Inhibition for the Prevention and Treatment of Diabetic Kidney Disease: A Review.

  2018cited by this paper
• Phenyl sulfate, indoxyl sulfate and p-cresyl sulfate decrease glutathione level to render cells vulnerable to oxidative stress in renal tubular cells

  2018cited by this paper
• Microbiota metabolites: Pivotal players of cardiovascular damage in chronic kidney disease

  2018cited by this paper
• Microbiota issue in CKD: how promising are gut-targeted approaches?

  2018cited by this paper
• Biochemical and Clinical Impact of Organic Uremic Retention Solutes: A Comprehensive Update

  2018cited by this paper
• 10. Microvascular Complications and Foot Care: Standards of Medical Care in Diabetes—2018

  2017cited by this paper
• Intestinal Microbiota in Type 2 Diabetes and Chronic Kidney Disease

  2017cited by this paper
• Wnt signaling and podocyte dysfunction in diabetic nephropathy

  2017cited by this paper
• Biomarkers of diabetic nephropathy: A 2017 update

  2017cited by this paper
• Alterations of intestinal barrier and microbiota in chronic kidney disease.

  2015cited by this paper
• Non-lethal Inhibition of Gut Microbial Trimethylamine Production for the Treatment of Atherosclerosis.

  2015cited by this paper
• Markers of and risk factors for the development and progression of diabetic kidney disease.

  2014cited by this paper
• Uremic solutes and risk of end stage renal disease in type 2 diabetes

  2014cited by this paper
• SLCO4C1 transporter eliminates uremic toxins and attenuates hypertension and renal inflammation.

  2009cited by this paper
• Metabolomics analysis reveals large effects of gut microflora on mammalian blood metabolites

  2009cited by this paper
• Isolation and characterization of a digoxin transporter and its rat homologue expressed in the kidney.

  2004cited by this paper

• Serum tyrosine increases all-cause mortality in an older population

  2025cites this paper
• Genetically Predicted Causal Risk Factors for Preeclampsia: A Comprehensive Mendelian Randomization Study

  2025cites this paper
• Machine-learning assisted discovery unveils novel interplay between gut microbiota and host metabolic disturbance in diabetic kidney disease

  2025cites this paper
• Dietary ginsenoside compound K alleviates renal inflammation and metabolic dysfunction induced by gut microbiota-derived imidazole propionate in diabetic mice

  2025cites this paper
• The effect of Zuogui-Jiangtang-Yishen decoction on the intestinal flora’s response to L-α-phosphatidylcholine and L-tyrosine in patients with diabetic kidney disease: an in vitro study

  2025cites this paper
• Impact of gut microbiota in chronic kidney disease: natural polyphenols as beneficial regulators

  2025cites this paper
• Traditional Chinese medicine improved diabetic kidney disease through targeting gut microbiota

  2024cites this paper
• Diabetic Kidney Disease: Contribution of Phenyl Sulfate Derived from Dietary Tyrosine upon Gut Microbiota Catabolism

  2024influential citation
• Gut microbiota in relationship to diabetes mellitus and its late complications with a focus on diabetic foot syndrome: A review

  2023cites this paper
• Intestinal microbiome diversity of diabetic and non-diabetic kidney disease: Current status and future perspective.

  2023cites this paper
• Current updates on metabolites and its interlinked pathways as biomarkers for diabetic kidney disease: a systematic review.

  2023cites this paper
• Metabolic Homeostasis of Amino Acids and Diabetic Kidney Disease

  2022cites this paper
• Research Progress of Intestinal Flora and Type 2 Diabetes Mellitus Microangiopathy

  2022cites this paper
• Contribution of Gut Microbiota-Derived Uremic Toxins to the Cardiovascular System Mineralization

  2021cites this paper
• Role of Gut Microbiota on Onset and Progression of Microvascular Complications of Type 2 Diabetes (T2DM)

  2020cites this paper
• Muscle mass assessment in renal disease: the role of imaging techniques.

  2020cites this paper
• Microbiome modulation to correct uremic toxins and to preserve kidney functions.

  2019cites this paper